Search
for

    Sort by

    Research 511–540 of 1000+

    1. 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials Journal of the American Academy of Dermatology · 2022 · 3 citations
    2. Alarmin Cytokines as Central Regulators of Cutaneous Immunity Frontiers in Immunology · 2022 · 51 citations
    3. Combination of light-emitting diode with minoxidil 2%, topical corticosteroid and oral immunomodulator induced hair regrowth in a pediatric alopecia areata Journal of Pakistan Association of Dermatologists · 2023
    4. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
    5. Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors Steroids · 2010 · 19 citations
    6. Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population Journal of Ovarian Research · 2014 · 10 citations
    7. New Synthesis of Finasteride Chinese Journal of Pharmaceuticals · 2003 · 1 citations
    8. 4. Bullous/Mucous Membrane Journal of Cutaneous Medicine and Surgery · 2003
    9. Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2 FEBS Open Bio · 2021 · 29 citations
    10. Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis Expert Review of Anticancer Therapy · 2017 · 28 citations
    11. Alopecia with Vitamin D-Dependent Rickets Type 2 A: A Case Report Clinical, cosmetic and investigational dermatology · 2024
    12. <i>Pinus thunbergii</i> bark extract rich in flavonoids promotes hair growth in dorsal skin by regulating inflammatory cytokines and increasing growth factors in mice Molecular Medicine Reports · 2022 · 5 citations
    13. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata JAMA Dermatology · 2023 · 1 citations
    14. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    15. The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent 2001 · 26 citations
    16. A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective 2020 · 4 citations
    17. Prooxidant and antioxidant action of 4-(4-phenoxybenzoyl)benzoic acid derivatives Biopolymers · 2004 · 2 citations
    18. 2 Cases of Alopecia areata treated with Korean Medicine The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology · 2018 · 1 citations
    19. 3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes Frontiers in cell and developmental biology · 2020 · 13 citations
    20. Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats Oxidative Medicine and Cellular Longevity · 2021 · 3 citations
    21. Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial medRxiv · 2026
    22. Molecular mechanisms underlying cashmere quality differences between Jiangnan cashmere goats and Changthangi pashmina goats Frontiers in Veterinary Science · 2025
    23. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis Journal of the American Academy of Dermatology · 2018 · 49 citations
    24. Synthesized Ceramide Induces Growth of Dermal Papilla Cells with Potential Contribution to Hair Growth 2019 · 7 citations
    25. A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata Journal of health economics and outcomes research · 2026
    26. Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study Clinical Drug Investigation · 2026
    27. Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals Journal of The American Academy of Dermatology · 2020 · 6 citations
    28. 2‐deoxy D‐glucose treatment does not elicit a hair growth response in alopecia areata Experimental Dermatology · 2019 · 4 citations
    29. Topical 4‐Aminopyridine 5% in Male Androgenetic Alopecia: A Split‐Scalp Exploratory Series Journal of Cosmetic Dermatology · 2026
    30. Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year Journal of the European Academy of Dermatology and Venereology · 2024